The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France
Open accessAbstract
Pseudomonas aeruginosa COL-1 was identified in a blood culture of a 39-year-old-woman treated with imipenem in Marseilles, France, in 1996. This strain was resistant to β-lactams, including ureidopenicillins, ticarcillin-clavulanic acid, cefepime, ceftazidime, imipenem, and meropenem, but remained susceptible to the monobactam aztreonam. The carbapenem-hydrolyzing β-lactamase gene of P. aeruginosa COL-1 was cloned, sequenced, and expressed in Escherichia coli DH10B. The deduced 266-amino-acid protein was an Ambler class B β-lactamase, with amino acid identities of 32% with B-II from Bacillus cereus ; 31% with IMP-1 from several gram-negative rods in Japan, including P. aeruginosa ; 27% with CcrA from Bacteroides fragilis ; 24% with BlaB from Chryseobacterium meningosepticum ; 24% with IND-1 from Chryseobacterium indologenes ; 21% with CphA-1 from Aeromonas hydrophila ; and 11% with L-1 from Stenotrophomonas maltophilia . It was most closely related to VIM-1 β-lactamase recently reported from Italian P. aeruginosa clinical isolates (90% amino acid identity). Purified VIM-2 β-lactamase had a pI of 5.6, a relative molecular mass of 29.7 kDa, and a broad substrate hydrolysis range, including penicillins, cephalosporins, cephamycins, oxacephamycins, and carbapenems, but not monobactams. As a metallo-β-lactamase, its activity was zinc dependent and inhibited by EDTA (50% inhibitory concentration, 50 μM). VIM-2 conferred a resistance pattern to β-lactams in E. coli DH10B that paralleled its in vitro hydrolytic properties, except for susceptibility to ureidopenicillins, carbapenems, and cefepime. bla VIM-2 was located on a ca. 45-kb plasmid that in addition conferred resistance to sulfamides and that was not self-transmissible either from P. aeruginosa to E. coli or from E. coli to E. coli. bla VIM-2 was the only gene cassette located within the variable region of a novel class 1 integron, In56, that was weakly related to the bla VIM-1 -containing integron. VIM-2 is the second carbapenem-hydrolyzing metalloenzyme characterized from a P. aeruginosa isolate outside Japan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
Nielsen, H., Engelbrecht, J., Brunak, S., & von Heijne, G. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.1.1 · Cited by 5,356
Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
Gene cassettes: a new class of mobile element
Recchia, G. D., & Hall, R. M. (1995) · Microbiology · doi:10.1099/13500872-141-12-3015 · Cited by 657
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Expression of antibiotic resistance genes in the integrated cassettes of integrons
Collis, C. M., & Hall, R. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.155 · Cited by 425
Carbapenem-hydrolyzing beta-lactamases
Rasmussen, B. A., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.223 · Cited by 361
Ullah, J. H., Walsh, T. R., Taylor, I. A., Emery, D. C., Verma, C. S., Gamblin, S. J., & Spencer, J. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2148 · Cited by 337
A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP
Arakawa, Y., Murakami, M., Suzuki, K., Ito, H., Wacharotayankun, R., Ohsuka, S., Kato, N., & Ohta, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1612 · Cited by 311
Structure and function of 59‐base element recombination sites associated with mobile gene cassettes
Stokes, H. W., O'Gorman, D. B., Recchia, G. D., Parsekhian, M., & Hall, R. M. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.6091980.x · Cited by 298
Cited by
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Multiplex PCR for detection of acquired carbapenemase genes
Poirel, L., Walsh, T. R., Cuvillier, V., & Nordmann, P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.12.002 · Cited by 1,991
Self-citationLogan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,584
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Self-citationCarbapenem resistance in Enterobacteriaceae: here is the storm!
Nordmann, P., Dortet, L., & Poirel, L. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.003 · Cited by 1,038
Self-citationEpidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 938
Bennett, P. M. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707607 · Cited by 893
Pseudomonas aeruginosa – a phenomenon of bacterial resistance
Strateva, T., & Yordanov, D. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009142-0 · Cited by 803
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Bonomo, R. A., & Szabo, D. (2006) · Clinical Infectious Diseases · doi:10.1086/504477 · Cited by 741
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Self-citationThe difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
Nordmann, P., & Poirel, L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12719 · Cited by 679
Self-citationMetallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 613
Yong, D., Lee, K., Yum, J. H., Shin, H. B., Rossolini, G. M., & Chong, Y. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3798-3801.2002 · Cited by 538
Lee, K., Lim, Y. S., Yong, D., Yum, J. H., & Chong, Y. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4623-4629.2003 · Cited by 514
Bebrone, C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.021 · Cited by 505
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
Pfeifer, Y., Cullik, A., & Witte, W. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.005 · Cited by 494
Lee, K., Chong, Y., Shin, H. B., Kim, Y. A., Yong, D., & Yum, J. H. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2001.00204.x · Cited by 446
Resistance integrons and super-integrons
Fluit, A. C., & Schmitz, F.-J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1198-743x.2004.00858.x · Cited by 419
Standard Numbering Scheme for Class B β-Lactamases
Galleni, M., Lamotte-Brasseur, J., Rossolini, G. M., Spencer, J., Dideberg, O., Frère, J.-M., & The Metallo-β-Lactamase Working Group (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.660-663.2001 · Cited by 414
Eliopoulos, G. M., & Bush, K. (2001) · Clinical Infectious Diseases · doi:10.1086/319610 · Cited by 392
Karampatakis, T., Tsergouli, K., & Behzadi, P. (2023) · Antibiotics · doi:10.3390/antibiotics12020234 · Cited by 339
Lee, K., Yum, J. H., Yong, D., Lee, H. M., Kim, H. D., Docquier, J.-D., Rossolini, G. M., & Chong, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4485-4491.2005 · Cited by 333
Detection of Pseudomonas aeruginosa Producing Metallo-β-Lactamases in a Large Centralized Laboratory
Pitout, J. D. D., Gregson, D. B., Poirel, L., McClure, J.-A., Le, P., & Church, D. L. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3129-3135.2005 · Cited by 331
Self-citationToleman, M. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf210 · Cited by 327
Carbapenemases: a problem in waiting?
Livermore, D. M., & Woodford, N. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00128-4 · Cited by 323
Mode of Action of Bi- and Trinuclear Zinc Hydrolases and Their Synthetic Analogues
Weston, J. (2005) · Chemical Reviews · doi:10.1021/cr020057z · Cited by 311
Carbapenemases: Molecular Diversity and Clinical Consequences
Poirel, L., Pitout, J. D., & Nordmann, P. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.501 · Cited by 309
Self-citationMolecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-09 · Cited by 307
Self-citationHammoudi Halat, D., & Ayoub Moubareck, C. (2020) · Antibiotics · doi:10.3390/antibiotics9040186 · Cited by 287
Update of the Standard Numbering Scheme for Class B β-Lactamases
Garau, G., García-Sáez, I., Bebrone, C., Anne, C., Mercuri, P., Galleni, M., Frère, J.-M., & Dideberg, O. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2347-2349.2004 · Cited by 286
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa
Hong, D. J., Bae, I. K., Jang, I.-H., Jeong, S. H., Kang, H.-K., & Lee, K. (2015) · Infection & Chemotherapy · doi:10.3947/ic.2015.47.2.81 · Cited by 271
Bahr, G., González, L. J., & Vila, A. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00138 · Cited by 266
Castanheira, M., Toleman, M. A., Jones, R. N., Schmidt, F. J., & Walsh, T. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4654-4661.2004 · Cited by 261
Crystal structure of NDM‐1 reveals a common β‐lactam hydrolysis mechanism
Zhang, G., & Hao, Q. (2011) · The FASEB Journal · doi:10.1096/fj.11-184036 · Cited by 253
Mobile Carbapenemase Genes in Pseudomonas aeruginosa
Yoon, E.-J., & Jeong, S. H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.614058 · Cited by 221
Shaaban, M. I., Shaker, M. A., & Mady, F. M. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0262-9 · Cited by 58
Metadata
- Authors
- Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J.-D., & Nordmann, P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-04
- Volume
- 44
- Issue
- 4
- Pages
- 891-897
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2129805236
- Cited by
- 562
- References
- 16
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.